Study of beta-thalassemia biomarkers and their relationship to cognition among children

Journal of Child Neurology

Volumn 25, Issue 12, 2010, Pages 1473-1479

  Shehata, Ghaydaa A ^a   Elsayh, Khaled I ^a   Rafet, Nafisa H ^a   Mohamed, Amany O ^a   Rageh, Tarek A ^a  

^a ASSIUT UNIVERSITY   (Egypt)

Author keywords

beta thalassemia; cognitive function; event related potentials; ferritin level; nitric oxide; serum transferrin receptors

Indexed keywords

BIOLOGICAL MARKER; FERRITIN; NITRIC OXIDE; TRANSFERRIN RECEPTOR;

ADOLESCENT; ARTICLE; BETA THALASSEMIA; BLOOD TRANSFUSION; CHILD; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD;

ADOLESCENT; BETA-THALASSEMIA; BIOLOGICAL MARKERS; BODY MASS INDEX; CHILD; COGNITION DISORDERS; FEMALE; HUMANS; MALE; SOCIOLOGY;

EID: 78650227699     PISSN: 08830738     EISSN: 17088283     Source Type: Journal    
DOI: 10.1177/0883073810368996     Document Type: Article

References (44)

1. Zafeiriou DI, Economy M., Athanasiou-Metaxa M. Neurological complications in beta-thalassemia. Brain Dev. 2006 ; 28: 477-481.
2. Shih YJ, Baynes RD, Hudson BG, et al. Serum transferrin receptor is a truncated form of tissue receptor. J Biol Chem. 1990 ; 265: 19077-19081.
3. R'Zik S., Loo M., Beguin Y. Reticulocyte transferrin receptor (TfR) expression and contribution to soluble transferrin receptor levels. Haematologica. 2001 ; 86: 244-251.
4. R'Zik S., Beguin Y. Serum soluble transferrin receptor concentration is an accurate estimate of the mass of tissue receptors. Exp Hematol. 2001 ; 29: 677-685.
5. Beguin Y., Huebers HA, Josephson B., Finch CA Transferrin receptors in rat plasma. Proc Natl Acad Sci USA. 1988 ; 85: 637-640.
6. Rother RP, Bell L., Hillmen P., Gladwin MT The clinical squeals of intravascular hemolysis and extracellular plasma hemoglobin. A novel mechanism of human disease. JAMA. 2005 ; 293: 1653-1662.
7. Wass C., Svensson L., Fejgin K., et al. Nitric oxide synthase inhibition attenuates phencyclidine-induced disruption of cognitive flexibility. Pharmacol Biochem Behav. 2008 ; 89: 352-359.
8. Mazzone L., Battaglia L., Andreozzi F., et al. Emotional impact in β-thalassaemia major children following cognitive-behavioral family therapy and quality of life of caregiving mothers. Clin Pract Epidemol Ment Health. 2009 ; 5: 5-9.
9. Economou M., Zafeiriou D., Kontopoulos E., et al. Neurophysiologic and intellectual evaluation of beta-thalassemia patients. Brain Dev. 2006 ; 28: 14-18.
10. Monastero R., Monastero G., Ciaccio C., et al. Cognitive deficits in beta-thalassemia major. Acta Neurol Scand. 2000 ; 102: 162-168.
11. Nedlman RD Growth and development. In: Nelson Textbook of Pediatrics. 17 th ed. Philadelphia, PA: Saunders ; 2004 :23.
12. Fahmy SI, El-Sherbini AF Determining simple parameters for social classification for health research. Bull High Inst Public Health. 1983 ; 8: 5-9.
13. Van Bezooijen RL, Que I., Ederveen AG, et al. Plasma nitrate + plasma nitrite are regulated by ovarian steroids but do not correlate with trabecular bone mineral density in rats. J Endocrinology. 1998 ; 159: 17-34.
14. Melika LK In: The Stanford-Binet Intelligence Scale, Arabic Examiner's Handbook. 4 th ed. Egypt, Cairo: Dar El-Maref Publishing ; 1998.
15. Delany EA, Hopkins TF In: The Stanford-Binet Intelligence Scale: Examiner's Handbook. 4 th ed. Chicago: Riverside Publishing Co ; 1986.
16. Hansch EC, Syndalko K., Cohen SN, et al. Cognition in Parkinson's disease: an event related potential prespective. Ann Neurol. 1982 ; 11: 599-607.
17. Uaprasert N., Rojnuckarin P., Bhokaisawan N., et al. Elevated serum transferrin receptor levels in common types of thalassemia heterozygotes in Southeast Asia: a correlation with genotypes and red cell indices. Clin Chim Acta. 2009 ; 403: 110-113.
18. Beguin Y., Clemons GK, Pootrakul P., Fillet G. Quantitative assessment of erythropoiesis and functional classification of anemia based on measurements of serum transferrin receptor and erythropoietin. Blood. 1993 ; 81: 1067-1076.
19. Punnonen K., Irjala K., Rajamaki A. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency anemia. Blood. 1997 ; 89: 1052-1057.
20. Demir A., Yarali N., Fisgin T., et al. Serum transferrin receptor levels in beta thalassemia trait. J Trop Pediatr. 2004 ; 50: 369-371.
21. Boonchalermvichian C., Paritpokee N., Bhokaisawan N., et al. Marked increase in serum transferrin receptor among Thai children with HbE beta-thalassemia. J Paediatr Child Health. 2002 ; 38: 601-603.
22. Rees DC, Williams TN, Maitland K., et al. Alpha thalassemia is associated with increased soluble transferrin receptor levels. Br J Haematol. 1998 ; 103: 365-369.
23. Skarmoutsou C., Papassotiriou I., Traeger-Synodinos J., et al. Erythroid bone marrow activity and red cell hemoglobinization in iron sufficient beta-thalassemia heterozygotes as reflected by soluble transferrin receptor and reticulocyte hemoglobin content. Correlation with genotypes and Hb A2 levels. Haematologica. 2003 ; 88: 631-636.
24. Bhokaisawan N., Paritpokee N., Wiwanitkit V., et al. Serum concentrations of soluble transferrin receptor among pediatric patients with transfusion-dependant beta-thalassaemia/haemoglobin E. Ann Trop Med Parasitol. 2002 ; 96: 427-429.
25. Ikram N., Hassan K., Younas M., Amanat S. Ferritin levels in patients of beta-thalassemia major. Int J Pathol. 2004 ; 2: 71-74.
26. Bayraktar N., Erkurt MA, Aydogdu I., Baflaran Y. The levels of nitric oxide in beta-thalassemia minor. Turk J Hematol. 2008 ; 25: 187-189.
27. Shehata GA, Elsayh KI, Mohamed AO, et al. Cognitive function and event related potentials in children with beta-thalassemia. Jour Pediat Neurol. 2010 ; [Epub ahead of print: DOI 10.3233/ JPN-2010-0388.].
28. Traeger-Synodinos J., Papassotiriou I., Vrettou C., et al. Erythroid marrow activity and functional anemia in patients with the rare interaction of a single functional α-globin and β-globin gene. Haematologica. 2001 ; 86: 363-367.
29. Cappellini MD Coagulation in the pathophysiology of hemolytic anemias. Hematology Am Soc Hematol Educ Program. 2007: 74-78.
30. Eldor A., Rachmilewitz EA The hypercoagulable state in thalassemia. Blood. 2002 ; 99: 36-43.
31. Lakhanpal V., Schocket S., Jiji R. Deferoxamine induced toxic retinal pigmentary degeneration and optic neuropathy. Ophthalmology. 1984 ; 91: 443-451.
32. Elwan O., Madkour O., Elwan F., et al. Brain aging in normal Egyptians: cognition, education, personality, genetic, and immunological study. J Neurol Sci. 2003 ; 122: 15-22.
33. Farrage AF, Khedr EM, Abdel- Aleem H., Rageh TA Effect of surgical menopause on cognitive functions. Dement Geriatr Cogn Disord. 2002 ; 13: 193-198.
34. Polich J., Starr A. Evoked potentials in aging. In: Albert ML, ed. Clinical Neurology of Aging. New York: Oxford University Press; 1984: 149-177.
35. Fukai M., Motomura N., Kobayashi S., et al. Event-related potential (P300) in epilepsy. Acta Neurol Scand. 1990 ; 82: 197-102.
36. Polich J. P300 in the evaluation of aging and dementia. In: Brunia M, Mulder G, Verbaten MN, eds. Event-Related Brain Potential Research: EEG Supplement. Amsterdam: Elsevier; 1991.
37. Steinrt JR, Kopp-Scheinpflug C., Challiss RA, et al. Nitric oxide is a volume transmitter regulating postsynaptic excitability at a glutamateric synapse. Neuron. 2008 ; 26: 642-656.
38. Lo L., Singer ST Thalassemia: current approach to an old disease. Pediatr Clin N Am. 2002 ; 49: 1165-1191.
39. Taher A., Ismaeel H., Cappellini M. Thalassemia intermedia: revisited. Blood Cells Mol Dis. 2006 ; 37: 12-20.
40. Pippard MJ, Callender ST, Warner GT, Weatherall DJ Iron absorption and loading in beta-thalassaemia intermedia. Lancet. 1979 ; 2: 819-821.
41. Naithani R., Chandra J., Bhattacharjee J., et al. Peroxidative stress and antioxidant enzymes in children with beta-thalassemia major. Pediatr Blood Cancer. 2006 ; 46: 780-785.
42. Borenstain-Ben YV, Barenholz Y., Hy-Am E., et al. Phosphatidylserine in the outer leaflet of red blood cells from beta-thalassemia patients may explain the chronic hypercoagulable state and thrombotic episodes. Am J Hematol. 1993 ; 44: 63-65.
43. Eldor A., Krausz Y., Atlan H., et al. Platelet survival in patients with beta-thalassemia. Am J Hematol. 1989 ; 32: 94-99.
44. Prati D. Benefits and complications of regular blood transfusion in patients with beta-thalassaemia major. Vox Sanguinis. 2000 ; 79: 129-137.